Skip to main content

Advertisement

SpringerLink
Log in

Hypersensitivity in muscle pain syndromes

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The aim of this review is to present research that has a bearing on the pathogenesis of hypersensitivity in muscle pain syndromes. Allodynia and hyperalgesia in these syndromes can be segmental or generalized and temporary or permanent. Hypersensitivity in muscle pain conditions in the clinic is best diagnosed by determining the pressure pain threshold. In a disorder such as fibromyalgia, decreased pain thresholds also are found at sites where there is no tenderness. Pathogenetic mechanisms for allodynia and hyperalgesia can be identified at several levels of the nociceptive system, from the nociceptors in the muscle to the cortex. Central sensitization of nociceptive neurons in the dorsal horn and a disturbed balance between inhibitory and facilitatory impulses in the descending tracts from the brain stem to the dorsal horn are the main mechanisms for pain hypersensitivity. Changes in function, biochemical make-up, and synaptic connections in the nociceptive neurons in the dorsal horn are considered to be caused by neuronal plasticity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Woolf CJ, Decosterd I: Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain Suppl 1999, 6:141–147. Guidelines for examination of patients with chronic pain regarding pain mechanisms are given.

    Article  Google Scholar 

  2. Pfeiffer-Jensen M: Pressure algometry on joints in rheumatoid arthritis. In Computer Controlled Pressure Algometry in Human Joints [itPhD Thesis]. Faculty of Health Sciences, Denmark: University of Aarhus Denmark; 1999:1–33.

    Google Scholar 

  3. Sörensen J, Graven-Nielsen T, Henriksson KG, et al.: Hyperexcitability in fibromyalgia. J Rheumatology 1998, 25:152–155.

    Google Scholar 

  4. Kosek E, Ekholm J, Hansson P: Sensory dysfunction in fibromyalgia patients with implications for pathogenic mechanisms. Pain 1996, 68:375–383.

    Article  PubMed  CAS  Google Scholar 

  5. Lautenbacher S, Rollman GB, McCain GA: Multimethod assessment of experimental and clinical pain in patients with fibromyalgia. Pain 1994, 59:45–53.

    Article  PubMed  CAS  Google Scholar 

  6. Rollman GB, Lautenbacher S: Sex differences in musculoskeletal pain. Clin J Pain 2001, 17:20–24.

    Article  PubMed  CAS  Google Scholar 

  7. Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science 2000, 288:1765–1768. This article deals with changes in nociceptive neurons that are considered to be expressions of neuronal plasticity. These changes can lead to pain hypersensitivity in chronic pain conditions such as chronic muscle pain.

    Article  PubMed  CAS  Google Scholar 

  8. Bengtsson A, Henriksson KG, Jorfelddt L, et al.: Primary fibromyalgia: a clinical and laboratory study of 55 patients. Scand J Rheumatol 1986, 15:340–347.

    PubMed  CAS  Google Scholar 

  9. Henriksson CH, Carlberg U, Henriksson KG, et al.: Fibromyalgia: Rapport Stimulansbidrag för habilitering och rehabilitering. Swedish National Board of Health and Welfare 2000, ISSN 1403–3348.

  10. Lápossy E, Maleitzke R, Hrycaj P, et al.: The frequency of transition of chronic low back pain to fibromyalgia. Scand J Rheumatol 1995, 24:29–53.

    PubMed  Google Scholar 

  11. Clauw DJ, Paul P: The overlap between fibromyalgia and inflammatory rheumatic diseases: when and why does it occur? J Clin Rheumatol 1995, 1:335–341.

    Article  CAS  PubMed  Google Scholar 

  12. Buskila D, Neumann L, Vaisberg G, et al.: Increased rates of fibromyalgia following cervical injury: a controlled study of 161 cases of traumatic injury. Arthritis Rheum 1997, 40:446–452.

    Article  PubMed  CAS  Google Scholar 

  13. Koelbaek Johansen M, Graven-Nielsen T, Schou Olesen A, Arendt-Nielsen L: Generalized muscular hyperalgesia in chronic whiplash syndrome. Pain 1999, 83:229–334.

    Article  PubMed  CAS  Google Scholar 

  14. Buskila D, Neumann L, Hazanov I, Carmi R: Familial aggregation in the fibromyalgia syndrome. Arthritis Rheum 1996, 26:605–611.

    Article  CAS  Google Scholar 

  15. Pillemer SR, Bradley LA, Crofford LJ, et al.: The neuroscience and endocrinology of fibromyalgia. Arthritis Rheum 1997, 40:1928–1939.

    Article  PubMed  CAS  Google Scholar 

  16. Martinez-Lavin M: The autonomic nervous system and fibromyalgia. J Musculoskel Pain 2002, 10:221–228.

    Article  Google Scholar 

  17. Chesterton LS, Barlas P, Foster NE, et al.: Gender differences in pressure pain threshold in healthy humans. Pain 2003, 101:259–266. The results presented in this article have bearing on the differences in pressure pain thresholds between men and women.

    Article  PubMed  Google Scholar 

  18. Vecchiet L: Muscle pain and aging. J Musculoskeletal Pain 2002, 10:5–22.

    Article  Google Scholar 

  19. Amandusson A, Hermanson O, Blomqvist A: Colocalization of oestrogen receptor immunoreactivity and preproenkephalin MRNA expression to neurons in the superficial laminae of the spinal and medullary dorsal horn of rats. Eur J Neurosci 1996, 8:2440–2445.

    Article  PubMed  CAS  Google Scholar 

  20. Buskila D, Neumann L, Odes LR, et al.: The prevalence of musculoskeletal pain and fibromyalgia in patients hospitalized on internal medicine wards. Arthritis Rheum 2001, 30:411–417.

    Article  CAS  Google Scholar 

  21. Torebjörk HE, Lundberg LE, LaMotte RH: Central changes in processing of mechanoreceptive input in capsaicin-induced secondary hyperalgesia in humans. J Physiology 1992, 448:765–780.

    Google Scholar 

  22. Torebjörk E: Subpopulations of human C nociceptors and their sensory correlates. In Proceedings of the 9th World Congress on Pain: Progress in Pain Research and Management, vol 16. Edited by Devor M, Rowbotham MC, Wiesenfeld-Hallin Z. Seattle: IASP Press; 2000:199–206.

    Google Scholar 

  23. Graven-Nielsen T, Mense S: The peripheral apparatus of muscle pain: evidence from animal and human studies. Clin J Pain 2001, 17:2–10. This is an up-to-date review.

    Article  PubMed  CAS  Google Scholar 

  24. Henriksson KG, Mense S: Pain and nociception in fibromyalgia: clinical and neurobiological considerations on aetiology and pathogenesis. Pain Reviews 1994, 1:245–260.

    Google Scholar 

  25. Lund N, Bengtsson A, Thorborg P: Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986, 15:165–173.

    PubMed  CAS  Google Scholar 

  26. Larsson B, Björk J, Henriksson KG, et al.: The prevalences of cytochrome c oxidase negative and superpositive fibres and ragged-red fibres in the trapezius muscle of female cleaners with and without myalgia and of female healthy controls. Pain 2000, 84:379–387.

    Article  PubMed  CAS  Google Scholar 

  27. Henriksson KG, Bengtsson A, Lindman R, Thornell LE: Morphological changes in muscle in fibromyalgia and chronic shoulder myalgia. In Progress in Fibromyalgia and Myofascial Pain. Edited by Vaeroy H, Merskey H. The Netherlands: Elsevier Science Publishers BV; 1993:61–73.

    Google Scholar 

  28. Larsson SE, Ålund M, Cai H, Öberg PÅ: Chronic pain after soft-tissue injury of the cervical spine: trapezius muscle blood flow and electromyography at static loads and fatigue. Pain 1994, 57:173–180.

    Article  PubMed  CAS  Google Scholar 

  29. Bengtsson M, Bengtsson A, Jorfeldt L: Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 1989, 39:171–180.

    Article  PubMed  CAS  Google Scholar 

  30. Eneström S, Bengtsson A, Frödin T: Dermal IgG deposits and increase of mast cells in patients with fibromyalgia: relevant findings or epiphenomena? Scand J Rheumatol 1997, 26:308–313.

    Article  PubMed  Google Scholar 

  31. Aspegren Kendall S, Henriksson KG, Hurtig I, et al.: Differences in sensory thresholds in the skin in women with the fibromyalgia syndrome: a comparison between ketamine responders and ketamine non-responders. J Musculoskeletal Pain, in press.

  32. Berglund B, Harju EL, Kosek E, Lindblom U: Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002, 96:177–187.

    Article  PubMed  Google Scholar 

  33. Mense S: Neurobiological concepts of fibromyalgia: the possible role of descending spinal tracts. Scand J Rheumatol 2000, 29(suppl 113):24–29. An up-to-date review.

    Article  Google Scholar 

  34. Ren K, Dubner R: Descending modulation in persistent pain: an update. Pain 2002, 100:1–6. Changes in descending modulation likely is an important pathogenic mechanism in disorders such as fibromyalgia. Current research is discussed in this article.

    Article  PubMed  Google Scholar 

  35. Vaeroy H, Helle R, Forre O, et al.: Elevated CSF levels of substance P and high incidence of Raynaud’s phenomenon in patients with fibromyalgia: new features for diagnosis. Pain 1988, 32:21–26.

    Article  PubMed  CAS  Google Scholar 

  36. Russell IJ, Orr MD, Littman B, et al.: Elevated cerebrospinal levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994, 37:593–1601.

    Article  Google Scholar 

  37. Lindh C, Liu Z, Lyrenäs S, et al.: Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997, 26:468–472.

    PubMed  CAS  Google Scholar 

  38. Bendtsen L, Nórregaard J, Jensen R, Olesen J: Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 1997, 401:98–102.

    Article  Google Scholar 

  39. Gibson SJ, Littlejohn GO, Gorman MM, et al.: Altered heat pain thresholds and cerebral event-related potentials following painful CO 2 laser stimulation in subjects with fibromyalgia syndrome. Pain 1994, 58:185–193.

    Article  PubMed  CAS  Google Scholar 

  40. Lorenz J, Grasedyck K, Bromm B: Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephalogr Clin Neurophysiol 1996, 100:165–168.

    Article  PubMed  CAS  Google Scholar 

  41. Price DD, Mao J, Frenk H, Mayer DJ: The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994, 59:165–174.

    Article  PubMed  CAS  Google Scholar 

  42. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, et al.: Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 2000, 85:483–491. Research concerning the role of activation of NMDA-receptors for muscle allodynia and hyperalgesia in fibromyalgia is presented in this article and in reference 43.

    Article  PubMed  CAS  Google Scholar 

  43. Price DD, Staud R, Robinson ME, et al.: Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients. Pain 2002, 99:49–59. This article and reference 42 deal with the role of activation of NMDA-receptors for allodynia/hyperalgesia in fibromyalgia.

    Article  PubMed  Google Scholar 

  44. Sörensen J, Bengtsson A, Bäckman E, et al.: Pain analysis in patients with fibromyalgia: effects of intravenous morphine, lidocaine, and ketamine. Scand J Rheumatol 1995, 14:360–365.

    Google Scholar 

  45. Sörensen J, Bengtsson A, Ahlner J, et al.: Fibromyalgia: Are there different mechanisms in the processing of pain? J Rheumatol 1997, 24:1615–1621.

    PubMed  Google Scholar 

  46. Kosek E, Hansson P: Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation [HNCS] in fibromyalgia patients and healthy subjects. Pain 1997, 70:41–51.

    Article  PubMed  CAS  Google Scholar 

  47. Kosek E, Ekholm J, Hansson P: Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain 1996, 64:415–423.

    Article  PubMed  CAS  Google Scholar 

  48. Staud R, Robinson ME, Vierck CJ Jr, Price DD: Diffuse noxious inhibitory controls [DNIC] attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003, 101:167–174.

    Article  PubMed  Google Scholar 

  49. Mountz JM, Bradley LA, Modell JG, et al.: Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995, 38:926–938.

    Article  PubMed  CAS  Google Scholar 

  50. Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002, 46:1333–1343. Does the hypersensitivity for pain in fibromyalgia result mainly from psychologic causes or does it have a biologic cause? The results presented in this article speak in favor of a biologic cause.

    Article  PubMed  Google Scholar 

  51. Flor H, Braun C, Elbert T, Birbaumer N: Extensive reorganization of primary somatosensory cortex in chronic back pain patients. Neurosci Lett 1997, 224:5–8. The results presented in this article show that chronic pain of peripheral origin (probably) can induce neuroplasticity changes in the cortex.

    Article  PubMed  CAS  Google Scholar 

  52. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for pathological pain. Trends Neurosci 2001, 24:450–455.

    Article  PubMed  CAS  Google Scholar 

  53. Samad TA, Moore KA, Sapirstein A, et al.: Interleukin-1 betamediated induction of cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471–475.

    Article  PubMed  CAS  Google Scholar 

  54. Ek M, Engblom D, Saha S, et al.: Pathway across the bloodbrain barrier. Nature 2001, 410:430–431.

    Article  PubMed  CAS  Google Scholar 

  55. Rollman GB, Lautenbacher S: Hypervigilance effects in fibromyalgia: pain experience and pain perception. In Progress in Fibromyalgia and Myofascial Pain. Edited by Vaeroy H, Merskey H. The Netherlands: Elsevier Science Publishers BV; 1993:149–159.

    Google Scholar 

  56. Keogh E, Mansoor L: Investigating the effects of anxiety sensitivity and coping on the perception of cold pressor pain in healthy women. Eur J Pain 2001, 5:11–25.

    Article  PubMed  CAS  Google Scholar 

  57. Crofford LJ, Clauw DJ: Fibromyalgia: Where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum 2002, 46:1136–1138.

    Article  PubMed  Google Scholar 

  58. Wolfe F, Smythe HA, Yunus MB, et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 22:160–172.

    Article  Google Scholar 

  59. Mense S, Simons DG, Russell J: Glossary. In Muscle Pain: Understanding Its Nature, Diagnosis, and Treatment. Philadelphia: Lippincott Williams & Wilkins; 2001:339–367.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rehabilitation Medicine, Faculty of Health Sciences,Linkoping University, Pain Clinic, University Hospital, SE-581 85, Linkoping, Sweden

    Karl G. Henriksson MD, PhD

Authors
  1. Karl G. Henriksson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henriksson, K.G. Hypersensitivity in muscle pain syndromes. Current Science Inc 7, 426–432 (2003). https://doi.org/10.1007/s11916-003-0058-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-003-0058-5

Keywords

Search

Navigation